Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Biofrontera

Ameluz Red-Light Therapy Wins FDA Approval for Superficial Basal Cell Carcinoma After Clearing 66% of Main Tumors

FDA-approved Ameluz gel with red-light therapy for superficial basal cell carcinoma. See the trial results, who may qualify, and what remains unknown.

Medical Daily · Sep 15

EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch

Pelthos Therapeutics Inc. (NYSE:PTHS) on Friday acquired the U.S. commercialization rights to Xepi (ozenoxacin) Cream, 1%, from Biofrontera Inc. (NASDAQ:BFRI) and Ferrer Internacional S.A.

Benzinga · Nov 7, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Benzinga · Apr 14, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Biofrontera Stock Is Surging Today

Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany.

Benzinga · Apr 13, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Benzinga · Apr 13, 2022

Earnings Scheduled For April 8, 2022

Companies Reporting Before The Bell • Biofrontera (NASDAQ:BFRI) is estimated to report quarterly loss at $0.18 per share on revenue of $9.24 million.

Benzinga · Apr 8, 2022

5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR Inc, Biofrontera And More

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if…

Benzinga · Feb 7, 2022

Read news from The Economist, FT, and more,
with one subscription

Why Are Biofrontera Shares Rising Today?

Biofrontera Inc (NASDAQ: BFRI) has provided an

Benzinga · Feb 1, 2022

Coverage From

Organisations

Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.